Survival for patients with multiple myeloma has significantly improved in the last decade in
large part due to the development of proteasome inhibitors and immunomodulatory drugs …

Abstract Purpose of Review The purpose of this review was to evaluate management
strategies for common adverse effects of novel therapies in multiple myeloma (MM) …

Simple Summary The treatment of patients with relapsed/refractory multiple myeloma has
advanced considerably in recent years, irrespective of whether they are younger or older …

Renal impairment is a common complication of multiple myeloma and deterioration in renal
function or renal failure may complicate clinical management. This retrospective study in …

Summary Here, the International Myeloma Working Group (IMWG) updates its clinical
practice recommendations for the management of multiple myeloma-related renal …

The treatment of multiple myeloma is considered a continuously evolving paradigm as a
result of the growing availability of new and highly effective drugs, including first-and second …

ABSTRACT Introduction: About 20–40% of patients with multiple myeloma (MM) will present
with some degree of renal impairment (RI) and about 25% of patients will experience RI at …

Opinion statement Multiple myeloma is frequently associated with renal dysfunction. In
addition, it has been shown that the presence of renal failure indicates a higher tumor …

Background Renal impairment (RI) is a common presenting complication of multiple
myeloma (MM); the availability of new treatments has improved the outcomes of patients …

Multiple myeloma (MM) is a plasma cell neoplasm often associated with renal impairment
(RI), with myeloma cast nephropathy recognized as the most common cause. While RI is …